» Authors » Annika Lindqvist

Annika Lindqvist

Explore the profile of Annika Lindqvist including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 363
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Melander E, Nielsen E, Lindqvist A, Hovd M, Gandia P, Panchaud A, et al.
Basic Clin Pharmacol Toxicol . 2024 Nov; 136(1):e14100. PMID: 39497323
Cetirizine is an antihistamine commonly used to treat allergic rhinitis and other allergic conditions. Cetirizine is often prescribed to breastfeeding mothers although there is limited information on infant exposure via...
2.
Diaz-Holguin A, Saarinen M, Vo D, Sturchio A, Branzell N, Cabeza de Vaca I, et al.
Sci Adv . 2024 Aug; 10(32):eadn1524. PMID: 39110804
Artificial intelligence is revolutionizing protein structure prediction, providing unprecedented opportunities for drug design. To assess the potential impact on ligand discovery, we compared virtual screens using protein structures generated by...
3.
Nordeng H, Wegler C, Lindqvist A, Melander E, Magnusson M, Gandia P, et al.
Basic Clin Pharmacol Toxicol . 2023 Oct; 134(1):153-164. PMID: 37811726
Data on drug transfer into human breast milk are sparse. This study aimed to quantify concentrations of cetirizine and levocetirizine in breast milk and to estimate drug exposure to infants....
4.
Wegler C, Saleh A, Lindqvist A, Nordeng H, Smeraglia J, Baranczewski P
J Chromatogr B Analyt Technol Biomed Life Sci . 2022 Jun; 1205:123340. PMID: 35732105
The majority of women have health problems that require medication after giving birth. Complications such as allergies, postpartum depression, and diabetes are often treated with drugs such as cetirizine, venlafaxine,...
5.
Lindqvist A, Friden M, Hammarlund-Udenaes M
Eur J Pharm Sci . 2016 Jul; 92:173-82. PMID: 27393342
The use of nanocarriers is an intriguing solution to increase the brain delivery of novel therapeutics. The aim of this paper was to use pharmacokinetic analysis and simulations to identify...
6.
Lindqvist A, Jonsson S, Hammarlund-Udenaes M
Mol Pharm . 2016 Feb; 13(4):1258-66. PMID: 26898546
To advance the development of peptide analogues for improved treatment of pain, we need to learn more about the blood-brain barrier transport of these substances. A low penetration into the...
7.
Lindqvist A, Rip J, van Kregten J, Gaillard P, Hammarlund-Udenaes M
Pharm Res . 2015 Aug; 33(1):177-85. PMID: 26275529
Purpose: The purpose of this study was to evaluate formulation factors causing improvement in brain delivery of a small peptide after encapsulation into a targeted nanocarrier in vivo. Methods: The...
8.
Lindqvist A, Manders D, Word R
BMC Res Notes . 2013 Feb; 6:34. PMID: 23363446
Background: Accurate measurements of mRNA expression levels in tissues or cells are crucially dependent on the use of relevant reference genes for normalization of data. In this study we used...
9.
Lindqvist A, Rip J, Gaillard P, Bjorkman S, Hammarlund-Udenaes M
Mol Pharm . 2012 Sep; 10(5):1533-41. PMID: 22934681
Glutathione PEGylated (GSH-PEG) liposomes were evaluated for their ability to enhance and prolong blood-to-brain drug delivery of the opioid peptide DAMGO (H-Tyr-d-Ala-Gly-MePhe-Gly-ol). An intravenous loading dose of DAMGO followed by...
10.
Lindqvist A, Jansson B, Hammarlund-Udenaes M
J Chromatogr B Analyt Technol Biomed Life Sci . 2012 Jun; 900:11-7. PMID: 22672845
A liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) method for the quantification of the opioid peptide DAMGO in rat plasma, as well as DAMGO and the microdialysis recovery calibrator [(13)C(2),(15)N]-DAMGO in...